Transforming Health
With BIOELECTRONICS

A highly scalable, fast and secure blockchain platform for distributed apps, enterprise use cases.

The problem

What we are solving

Portability
Compatibility with digital life
Integration in lab-on-a-chip devices

Donec quam lectus vel vulputate mauris. Nullam quam amet adipiscing quis diam nisl maecenas. Ornare fermentum ullamcorper ut ullamcorper amet. Tincidunt sed amet.

Healthcare is about prevention, and that is really becoming possible by digital portable diagnostic devices integrated into our digital life.

Existing biosensors can perform only a low number of -and similar- diagnostic assays.
A biosensor consists of a detection element, the molecular probe, that binds to a biomarker and generates an electrical signal.
The main difficulty is obtaining the probes; unlike in the pharmaceutical industry, there is no specific methodology for digital biosensor discovery.

01 / THROUGHPUT

We manufacture synthetic DNA-derived molecules and large combinatorial libraries in predefined locations for mass-screening of important biological molecules

02 / DIGITAL

With CMOS technology we can unleash the full potential of digital diagnostic assays and transform molecular interactions into measurable signals

03 / APTIVEX

This is the branded name of our high-throughput technology for the discovery of novel biosensing molecules for electrochemical devices
the solution

Our technology

Imperdiet lorem condimentum sit augue. Amet consequat nec congue ut senectus enim mattis sit. Nisi commodo venenatis posuere sit at, venenatis. Gravida nulla facilisis

Aplife introduces the first digital probe discovery platform designed to develop a new generation of digital devices. Biosensor companies will quickly, accurately, and cost-effectively discover new receptors that can be applied to new biosensing devices.

Two main pillars sustain it:

In-situ fabrication of millions of receptor candidates in predefined locations.
A proprietary semiconductor to massively test these candidates digitally.
Contact Us
Our technology will be the foundation of new point-of-care biomarker panel tests, proteome assays, the early detection of disease, and the routine monitoring of risk factors in people, the environment, and veterinary.
discovery of novel biosensing molecules

APTIVEX
TECHNOLOGY

Smart library
generation
Library
synthesis
Screening
Probes detection
Delivery

HIGHER SUCCESS RATES

With synthesis cycles of just few hours, finding leads and improving their kinetics can be done in only a few days, facilitating decisions and  transforming a discovery process in a more accessible and predictable process.

FASTER TURNAROUND
TIMES

With synthesis cycles of just few hours, finding leads and improving their kinetics can be done in only a few days, facilitating decisions and  transforming a discovery process in a more accessible and predictable process.

UNPRECEDENT
MOLECULES

Our aptamer synthesis enables the usage of unlimited modifications adding chemical information to DNA aptamers and improving molecular interactions. With bioinformatic approaches, we will design smart chemical diversity in order to obtain effective combinatorial libraries
investors and collaborators

WE ARE NOT ALONE

We’re proud to share our journey with world-class supporters.

Blog

Latest news on aplife